The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study

BACKGROUND: Although a few meta-analyses were conducted to compare the risk of incident atrial fibrillation (AF) between sodium-glucose cotransporter-2 inhibitor (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), and other anti-hyperglycemic agents using indirect or direct comparison, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Yi-Hsin, Chao, Tze-Fan, Chen, Shao-Wei, Lee, Hsin-Fu, Li, Pei-Ru, Chen, Wei-Min, Yeh, Yung-Hsin, Kuo, Chi-Tai, See, Lai-Chu, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241240/
https://www.ncbi.nlm.nih.gov/pubmed/35765074
http://dx.doi.org/10.1186/s12933-022-01549-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241240/
https://www.ncbi.nlm.nih.gov/pubmed/35765074
http://dx.doi.org/10.1186/s12933-022-01549-x

Ejemplares similares